Report Overview
The Gene Synthesis Market refers to the global industry focused on the artificial creation of DNA sequences or genes in laboratories, using chemical synthesis.
This technology enables researchers and companies to design and construct genetic materials without the need for a pre-existing DNA template.
Gene synthesis is an essential tool in synthetic biology, biotechnology, and genomics, facilitating advances in areas such as drug development, agriculture, and genetic engineering.
Key products include synthetic DNA, oligonucleotides, and custom genes, which are used across various industries for research, therapeutics, and industrial applications.
Market Analysis
In 2023, the global Gene Synthesis market was valued at US$ 576 million and is projected to grow to US$ 1,661 million by 2030, registering a compound annual growth rate (CAGR) of 16.35% during the forecast period of 2024 to 2030. This robust growth reflects the increasing adoption of gene synthesis technologies across sectors like biotechnology, pharmaceuticals, and academic research.
North America accounted for a significant share of the market, valued at US$ 198.42 million in 2023, and is expected to reach US$ 477 million by 2030, with a CAGR of 13.48%.
Asia-Pacific, on the other hand, is witnessing exponential growth, increasing from US$ 209.61 million in 2023 to US$ 748.59 million by 2030, at an impressive CAGR of 19.77%.
The European market and other regions like the Middle East and South America also contribute significantly, driven by advancements in synthetic biology and growing investments in research.
